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The Pandanus (family: Pandanaceae) are Asia Pacific 
plants with approximately 800 species. They are 
used traditionally for various purposes. Researchers 
investigate the medicinal values of these plants and 
interestingly, they provide scientific evidences showing 
that the plant extracts exhibited biopharmaceutical 
properties. Thus, this study aims to investigate the 
plant concerning the phytochemical aspect through 
its chromatographic profile and analysis using 
spectroscopy, crystallography and microscopy. This 
study was conducted on six locally available Pandanus 
species, namely P. pygmaeus, P. sanderi, P. tectorius, 
P. dubius, P. conoideus and P. amaryllifolius. Out of 
these species, only P. amaryllifolius was studied by 
Malaysian scientists. Meanwhile, three other species (P. 
tectorius, P. dubius and P. conoideus) were examined 
by the Philippines and Indonesian counterparts. This 
work was also emphasized on another two pandans 
(P. pygmaeus and P. sanderi), which have never been 
studied before. Thus, the samples were extracted 
in relatively small scale (less than one kilogram) 
and the solvents were recycled during the crude 
extraction. The extractions were based on both acid 
base and normal procedures, depending upon the 
targeted compounds. As for the fractionation and 
isolation, a range of chromatographic techniques were 
performed such as Silica Gel Column Chromatography 
(SGCC), preparative Thin Layer Chromatography 
(TLC), both normal and reverse phase medium, plus 
high performance liquid chromatographies (HPLC), 
utilizing ultraviolet detector. Nearly ninety moieties 
were successfully separated, exclusively based 
Kidney transplantation is widely accepted to be the 
best option for patients with end-stage kidney disease. 
After transplantation patients would be maintained on 
immunosuppressive agents to lower the activity of their 
immune system and vigilant surveillance is important 
to monitor other post-transplant complications. 
on the HPLC chromatograms. The identification and 
characterization of pure substituents were accomplished 
by using the standard Nuclear Magnetic Resonance 
(NMR) spectroscopic analysis, Time-of-Flight Liquid 
Chromatography-Mass Spectrometry (TOF LC-MS) 
and X-ray crystallography of pure crystals. However, 
merely seven chemical entities were fully recognized 
from this Pandanus study. Three molecules from P. 
pygmaeus consist of stigmasterol, lignan and a novel 
pandan alkaloid, practically called as Pygmaeusamine. 
Two compounds from P. sanderi include one saponin 
(lanostane-type) and saponoside (b-sitosterol 
glucoside), respectively. Initial discovery included a 
compound which was comparable to a tirucallane-type 
triterpene. However, after a detailed inspection from 
the X-ray crystallography asessment, it was revealed 
that the compound has a different carbon skeleton from 
previously isolated triterpene from Pandanus species 
and was classified as a lanostane-type triterpene. In 
the case of P. tectorius, two chemical components were 
known as a steroid alkaloid and an esterified triterpenoid. 
Meanwhile, the root of P. amaryllifolius possibly contains 
the same alkaloid as found in P. tectorius. Still, the 
isolated moieties from P. dubius and P. conoideus 
were partially elucidated and cannot be completely 
characterized due to the insufficient amount of pure 
samples. In addition, the microscopic analysis revealed 
the presence of raphide-type crystals of calcium oxalate. 
In short, this is the first documented occurrence of novel 
Pandanus alkaloid, steroid alkaloid and saponoside from 
Pandanus.
Tacrolimus (FK506) is a calcineurin inhibitor that has 
been widely used as an immunosuppressive agent in 
patients undergoing organ transplantation. However, 
its clinical use is complicated due to its narrow 
therapeutic window and wide interindividual variation of 
responses to immunosuppressive therapy. Therefore, 
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This study concerns the anthropomorphic animal 
folktale namely Sang Kancil: The Animated Series 
(SKTAS) produced by Filem Negara Malaysia (National 
Film Department) during the late 1970s and early 
1980s. These animated series are Hikayat Sang Kancil 
(Xavier, A, 1978); Sang Kancil & Monyet, (Hassan Abd 
Muthalib, 1984); and Sang Kancil & Buaya (Hassan 
Abd Muthalib, 1987). In general, the study comprises 
of two parts, Historical Perspective and Analytical 
Perspective. In the first part, the study attempts to 
establish insight regarding the historical background 
of the agency. Here it identifies some of the important 
historical events which are crucial for the development 
of animation production in this country. These events 
are found in three major periods, Colonial (1949-1956), 
Post-Colonial (1957-1960), Contemporary (1970-
2000). Among the topics discussed in this section, 
includes the establishment of the Malayan Film Unit 
and Film Negara Malaysia, the contribution made by 
animation pioneers and the review of anthropomorphic 
animal folktale from 1970 to 2000. In the second part, 
the study looks at the construction of Sang Kancil: 
The Animated Series (SKTAS) by analyzing three 
important aspects, Cinematic Composition, Narrative 
Structure and Semiotics. Here, it poses the question 
of what formula did the artist employ to construct the 
animated series (SKTAS). In context of cinematic, a mix 
method (qualitative & quantitative) was explored which 
include a Shot-by-shot analysis and a Statistical Style 
Analysis (Salt, 1974). This approach aims to establish 
baseline information regarding the cinematic convention 
(Duration, Setting and Camera Technique). In context of 
Narrative, a method called Freytag‘s Pyramid Analysis 
(Freytag, 1893 cited in Griffith, 2011) was employed. 
This approach enables the researcher to analyze the 
narrative structure of the samples thus determining 
its characteristics (Exposition, Rising Action, Climax, 
Falling Action and Resolution). In context of Semiotics, 
the study attempts to identify the symbolism element 
called ‗Signifier and Signified‘ (Saussure, 1966 cited 
in Berger, 1992) and interpreting its meaning in relation 
to Malaysian history, politics and culture. The study 
concludes with a summary of the findings from the earlier 
chapters (Chapter Four, Chapter Five & Chapter Six).
it remains a challenge for clinicians to optimize the 
immunosuppressive drug to minimize the risk of 
rejection and at the same time avoid toxicity despite 
conventional therapeutic drug monitoring (TDM) being 
performed. In addition, the determination of toxicity and 
rejection still solely depend on the invasive procedure of 
biopsy. Thus, this study aims to investigate the impact 
of pharmacogenomics and metabolomics in monitoring 
the efficacy of tacrolimusand other post-transplant 
complications. A total of 282 healthy controls and 80 
kidney transplant patients treated with tacrolimus 
from three major ethnic groups (Malay, Chinese and 
Indians) were recruited. Blood and serum samples 
were collected to obtain DNA, RNA and metabolites 
and clinical data of the patients were also collected. For 
patients and healthy controls samples, the distribution 
of three ABCB1 SNPs were investigated (C1236T, 
G2677T/A and C3435T) and were found to be in high 
frequency as being reported by other Asian population. 
However no correlation was observed between these 
SNPs and clinical outcomes. Exploration of CYP3A5 
A6986G distribution among patients reveals that the 
frequency of variant allele (CYP3A5*3) to be in high 
frequency. The homozygous variant genotype (CYP3A5 
non-expressor) was significantly correlated with low 
dose requirement but high level of dose-adjusted ratio 
for tacrolimus. This genotype was also found to be 
significantly high among Chinese patients who exhibited 
similar trend of tacrolimus dose and dose-adjusted ratio. 
Absolute quantification of ABCB1 blood mRNA level 
using quantative PCR (qPCR) reveals that the expression 
level was heterogenous although the variation cannot 
be explained by the C1236T, G2677T/A, C3435T or the 
haplotypes. However, a significant inverse correlation 
was demonstrated between ABCB1 mRNA level and 
tacrolimus doseadjusted ratio that highlights the need for 
the search of other causal variants for ABCB1. Global 
metabolite profiling using Quadrupole Time-of-Flight 
(Q-TOF) LC/MS platform of patients and healthy controls’ 
sera as well as patients with other criteria demonstrated 
plenty of compounds that were in different abundance. 
A total of 9 groups of compound were found to have 
potential to be developed into biomarkers. However, all of 
these potential compounds need to be further validated 
before being introduced into clinical setting. This pilot 
study demonstrates the potential of integration between 
pharmacogenomics and metabolomics to complement 
conventional therapeutic drug monitoring practice and to 
assist physicians in achieving the target of personalized 
medicine.
